← All trials
NCT02302547
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2014
- Primary completion
- Aug 1, 2017
- Completion date
- Aug 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 250
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of ToulouseLead sponsor
- Centre Hospitalier of ChartresCollaborator
- University of Caen-NormandieOverall official - principal investigator
- Centre Hospitalier of ChartresOverall official - principal investigator
- CH de SAINTESOverall official - principal investigator
- CHU SAINT LOUISOverall official - principal investigator
- CH de NIORTOverall official - principal investigator
- Centre Hospitalier de TourcoingOverall official - principal investigator
- University of ParisOverall official - principal investigator
- Centre Hospitalier de La RochelleOverall official - principal investigator
- CHU Henri MondorOverall official - principal investigator
- University of LorraineOverall official - principal investigator
- Rouen Normandy UniversityOverall official - principal investigator
- University of LorraineCollaborator
- Rouen Normandy UniversityCollaborator
- University of La RochelleCollaborator
- ORLEANS hospitalCollaborator
- SAINTES HospitalCollaborator
- Centre Hospitalier de TourcoingCollaborator
- CH de NIORTCollaborator
- University of VersaillesCollaborator
- CHU Henri MondorCollaborator
- University of VersaillesOverall official - principal investigator
- University of PoitiersOverall official - principal investigator
- University of PoitiersCollaborator
- University of ParisCollaborator
- University of Caen-NormandieCollaborator
- François Rabelais UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.